Atlas Trials

RCT of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Ocular Adnexal MALT Lymphoma

Clinical trial NCT06064344 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06064344
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Ocular Adnexal MALT Lymphoma
Start date
2023-10-07
Primary completion
2027-10-06
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.